{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:59:26Z","timestamp":1776884366363,"version":"3.51.2"},"reference-count":53,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science and Technology Council","award":["NSTC-112-2320-B-038-013"],"award-info":[{"award-number":["NSTC-112-2320-B-038-013"]}]},{"name":"National Science and Technology Council","award":["NSTC-112-2636-B-A49-007"],"award-info":[{"award-number":["NSTC-112-2636-B-A49-007"]}]},{"name":"National Science and Technology Council","award":["MOST-111-2628-B-038-002"],"award-info":[{"award-number":["MOST-111-2628-B-038-002"]}]},{"name":"National Science and Technology Council","award":["MOST-109-2811-B-038-544"],"award-info":[{"award-number":["MOST-109-2811-B-038-544"]}]},{"name":"National Science and Technology Council","award":["MOST-112-2314-B-038-097"],"award-info":[{"award-number":["MOST-112-2314-B-038-097"]}]},{"name":"National Science and Technology Council","award":["MOST-110-2314-B-038-134"],"award-info":[{"award-number":["MOST-110-2314-B-038-134"]}]},{"name":"National Science and Technology Council","award":["110TMU-SHH-23"],"award-info":[{"award-number":["110TMU-SHH-23"]}]},{"name":"National Science and Technology Council","award":["112FRP-12"],"award-info":[{"award-number":["112FRP-12"]}]},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["NSTC-112-2320-B-038-013"],"award-info":[{"award-number":["NSTC-112-2320-B-038-013"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["NSTC-112-2636-B-A49-007"],"award-info":[{"award-number":["NSTC-112-2636-B-A49-007"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST-111-2628-B-038-002"],"award-info":[{"award-number":["MOST-111-2628-B-038-002"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST-109-2811-B-038-544"],"award-info":[{"award-number":["MOST-109-2811-B-038-544"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST-112-2314-B-038-097"],"award-info":[{"award-number":["MOST-112-2314-B-038-097"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST-110-2314-B-038-134"],"award-info":[{"award-number":["MOST-110-2314-B-038-134"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["110TMU-SHH-23"],"award-info":[{"award-number":["110TMU-SHH-23"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["112FRP-12"],"award-info":[{"award-number":["112FRP-12"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shuang Ho Hospital","award":["NSTC-112-2320-B-038-013"],"award-info":[{"award-number":["NSTC-112-2320-B-038-013"]}]},{"name":"Shuang Ho Hospital","award":["NSTC-112-2636-B-A49-007"],"award-info":[{"award-number":["NSTC-112-2636-B-A49-007"]}]},{"name":"Shuang Ho Hospital","award":["MOST-111-2628-B-038-002"],"award-info":[{"award-number":["MOST-111-2628-B-038-002"]}]},{"name":"Shuang Ho Hospital","award":["MOST-109-2811-B-038-544"],"award-info":[{"award-number":["MOST-109-2811-B-038-544"]}]},{"name":"Shuang Ho Hospital","award":["MOST-112-2314-B-038-097"],"award-info":[{"award-number":["MOST-112-2314-B-038-097"]}]},{"name":"Shuang Ho Hospital","award":["MOST-110-2314-B-038-134"],"award-info":[{"award-number":["MOST-110-2314-B-038-134"]}]},{"name":"Shuang Ho Hospital","award":["110TMU-SHH-23"],"award-info":[{"award-number":["110TMU-SHH-23"]}]},{"name":"Shuang Ho Hospital","award":["112FRP-12"],"award-info":[{"award-number":["112FRP-12"]}]},{"name":"Center for Intelligent Drug Systems and Smart Bio-devices (IDS2B) of the Higher Education Sprout Project (HESP)","award":["NSTC-112-2320-B-038-013"],"award-info":[{"award-number":["NSTC-112-2320-B-038-013"]}]},{"name":"Center for Intelligent Drug Systems and Smart Bio-devices (IDS2B) of the Higher Education Sprout Project (HESP)","award":["NSTC-112-2636-B-A49-007"],"award-info":[{"award-number":["NSTC-112-2636-B-A49-007"]}]},{"name":"Center for Intelligent Drug Systems and Smart Bio-devices (IDS2B) of the Higher Education Sprout Project (HESP)","award":["MOST-111-2628-B-038-002"],"award-info":[{"award-number":["MOST-111-2628-B-038-002"]}]},{"name":"Center for Intelligent Drug Systems and Smart Bio-devices (IDS2B) of the Higher Education Sprout Project (HESP)","award":["MOST-109-2811-B-038-544"],"award-info":[{"award-number":["MOST-109-2811-B-038-544"]}]},{"name":"Center for Intelligent Drug Systems and Smart Bio-devices (IDS2B) of the Higher Education Sprout Project (HESP)","award":["MOST-112-2314-B-038-097"],"award-info":[{"award-number":["MOST-112-2314-B-038-097"]}]},{"name":"Center for Intelligent Drug Systems and Smart Bio-devices (IDS2B) of the Higher Education Sprout Project (HESP)","award":["MOST-110-2314-B-038-134"],"award-info":[{"award-number":["MOST-110-2314-B-038-134"]}]},{"name":"Center for Intelligent Drug Systems and Smart Bio-devices (IDS2B) of the Higher Education Sprout Project (HESP)","award":["110TMU-SHH-23"],"award-info":[{"award-number":["110TMU-SHH-23"]}]},{"name":"Center for Intelligent Drug Systems and Smart Bio-devices (IDS2B) of the Higher Education Sprout Project (HESP)","award":["112FRP-12"],"award-info":[{"award-number":["112FRP-12"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>The management of chronic myelogenous leukemia (CML) has seen significant progress with the introduction of tyrosine kinase inhibitors (TKIs), particularly Imatinib. However, a notable proportion of CML patients develop resistance to Imatinib, often due to the persistence of leukemia stem cells and resistance mechanisms independent of BCR::ABL1 This study investigates the roles of IL6R, IL7R, and MYC in Imatinib resistance by employing CRISPR\/Cas9 for gene editing and the Non-Invasive Apoptosis Detection Sensor version 2 (NIADS v2) for apoptosis assessment. The results indicate that Imatinib-resistant K562 cells (K562-IR) predominantly express IL6R, IL7R, and MYC, with IL6R and MYC playing crucial roles in cell survival and sensitivity to Imatinib. Conversely, IL7R does not significantly impact cytotoxicity, either alone or in combination with Imatinib. Further genetic editing experiments confirm the protective functions of IL6R and MYC in K562-IR cells, suggesting their potential as therapeutic targets for overcoming Imatinib resistance in CML. This study contributes to understanding the mechanisms of Imatinib resistance in CML, proposing IL6R and MYC as pivotal targets for therapeutic strategies. Moreover, the utilization of NIADS v2 enhances our capability to analyze apoptosis and drug responses, contributing to a deeper understanding of CML pathogenesis and treatment options.<\/jats:p>","DOI":"10.3390\/cells13070616","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:58:38Z","timestamp":1712105918000},"page":"616","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unveiling IL6R and MYC as Targeting Biomarkers in Imatinib-Resistant Chronic Myeloid Leukemia through Advanced Non-Invasive Apoptosis Detection Sensor Version 2 Detection"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6015-2239","authenticated-orcid":false,"given":"Chia-Hwa","family":"Lee","sequence":"first","affiliation":[{"name":"School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, New Taipei City 23561, Taiwan"},{"name":"Ph.D. Program in Medicine Biotechnology, College of Medical Science and Technology, Taipei Medical University, New Taipei City 23561, Taiwan"},{"name":"TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan"},{"name":"Center for Intelligent Drug Systems and Smart Bio-Devices (IDS2B), National Yang Ming Chiao Tung University, Hsinchu 30068, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Wen","family":"Hsu","sequence":"additional","affiliation":[{"name":"Research Center for Cancer Biology, China Medical University, Taichung City 40402, Taiwan"},{"name":"Institute of Translational Medicine and New Drug Development, China Medical University, Taichung City 40402, Taiwan"},{"name":"Program for Cancer Biology and Drug Discovery, Drug Development Center, China Medical University, Taichung City 40402, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Yu","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan"},{"name":"Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ting","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Physiology, UT Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Long","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK"},{"name":"Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford OX3 7BN, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2901-2681","authenticated-orcid":false,"given":"Chun-Yu","family":"Lin","sequence":"additional","affiliation":[{"name":"Center for Intelligent Drug Systems and Smart Bio-Devices (IDS2B), National Yang Ming Chiao Tung University, Hsinchu 30068, Taiwan"},{"name":"Institute of Bioinformatics and Systems Biology, National Yang Ming Chiao Tung University, Hsinchu 30068, Taiwan"},{"name":"School of Dentistry, Kaohsiung Medical University, Kaohsiung 807378, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Huey","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan"},{"name":"Department of Pediatrics, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","article-title":"Global estimates of incidence and mortality of cervical cancer in 2020: A baseline analysis of the WHO Global Cervical Cancer Elimination Initiative","volume":"11","author":"Singh","year":"2023","journal-title":"Lancet Glob. Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.18632\/aging.100934","article-title":"Apoptosis as anticancer mechanism: Function and dysfunction of its modulators and targeted therapeutic strategies","volume":"8","author":"Pistritto","year":"2016","journal-title":"Aging"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: A review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(02)00096-X","article-title":"Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia","volume":"2","author":"Shah","year":"2002","journal-title":"Cancer Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/2040620712468289","article-title":"Management of imatinib-resistant patients with chronic myeloid leukemia","volume":"4","author":"Bhamidipati","year":"2013","journal-title":"Ther. Adv. Hematol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/asheducation-2009.1.461","article-title":"Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance","volume":"2009","author":"Bixby","year":"2009","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1470-2045(11)70201-7","article-title":"Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial","volume":"12","author":"Kantarjian","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0092-8674(03)00190-9","article-title":"Mechanisms of autoinhibition and STI-571\/imatinib resistance revealed by mutagenesis of BCR-ABL","volume":"112","author":"Azam","year":"2003","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.bbapap.2012.12.009","article-title":"Mechanisms of resistance to BCR-ABL and other kinase inhibitors","volume":"1834","author":"Lamontanara","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/jnci\/djx236","article-title":"Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition","volume":"110","author":"Mitchell","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/blood-2017-07-792143","article-title":"Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment","volume":"130","author":"Issa","year":"2017","journal-title":"Blood"},{"key":"ref_12","first-page":"243","article-title":"Resistant mutations in CML and Ph(+)ALL\u2014Role of ponatinib","volume":"8","author":"Miller","year":"2014","journal-title":"Biologics"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1158\/0008-5472.CAN-05-0259","article-title":"In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants","volume":"65","author":"Walters","year":"2005","journal-title":"Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Alves, R., Goncalves, A.C., Rutella, S., Almeida, A.M., De Las Rivas, J., Trougakos, I.P., and Sarmento Ribeiro, A.B. (2021). Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia-From Molecular Mechanisms to Clinical Relevance. Cancers, 13.","DOI":"10.3390\/cancers13194820"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-018-0624-2","article-title":"Past, present, and future of Bcr-Abl inhibitors: From chemical development to clinical efficacy","volume":"11","author":"Rossari","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3389\/fonc.2019.00939","article-title":"BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia","volume":"9","author":"Loscocco","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.stem.2008.11.015","article-title":"Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells","volume":"4","author":"Somervaille","year":"2009","journal-title":"Cell Stem Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s13287-021-02659-1","article-title":"Chronic myeloid leukemia stem cells: Targeting therapeutic implications","volume":"12","author":"Mojtahedi","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s10495-022-01735-y","article-title":"Programmed cell death detection methods: A systematic review and a categorical comparison","volume":"27","author":"Kari","year":"2022","journal-title":"Apoptosis"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Hsu, K.W., Huang, C.Y., Tam, K.W., Lin, C.Y., Huang, L.C., Lin, C.L., Hsieh, W.S., Chi, W.M., Chang, Y.J., and Wei, P.L. (2018). The Application of Non-Invasive Apoptosis Detection Sensor (NIADS) on Histone Deacetylation Inhibitor (HDACi)-Induced Breast Cancer Cell Death. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19020452"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Chen, S.H., Chow, J.M., Hsieh, Y.Y., Lin, C.Y., Hsu, K.W., Hsieh, W.S., Chi, W.M., Shabangu, B.M., and Lee, C.H. (2019). HDAC1,2 Knock-Out and HDACi Induced Cell Apoptosis in Imatinib-Resistant K562 Cells. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092271"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/jnci\/djq300","article-title":"Overexpression and activation of the alpha9-nicotinic receptor during tumorigenesis in human breast epithelial cells","volume":"102","author":"Lee","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Tu, S.H., Hsieh, Y.C., Huang, L.C., Lin, C.Y., Hsu, K.W., Hsieh, W.S., Chi, W.M., and Lee, C.H. (2017). A rapid and quantitative method to detect human circulating tumor cells in a preclinical animal model. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3419-x"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12935-015-0240-y","article-title":"Ideal sphere-forming culture conditions to maintain pluripotency in a hepatocellular carcinoma cell lines","volume":"15","author":"Min","year":"2015","journal-title":"Cancer Cell Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4062\/biomolther.2020.205","article-title":"Platelet-Derived Growth Factor Receptor-alpha Subunit Targeting Suppresses Metastasis in Advanced Thyroid Cancer In Vitro and In Vivo","volume":"29","author":"Lin","year":"2021","journal-title":"Biomol. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Abbasalipour, M., Khosravi, M.A., Zeinali, S., Khanahmad, H., Karimipoor, M., and Azadmanesh, K. (2019). Improvement of K562 Cell Line Transduction by FBS Mediated Attachment to the Cell Culture Plate. Biomed Res. Int., 2019.","DOI":"10.1155\/2019\/9540702"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4062\/biomolther.2016.162","article-title":"LncRNA MEG3 Regulates Imatinib Resistance in Chronic Myeloid Leukemia via Suppressing MicroRNA-21","volume":"25","author":"Zhou","year":"2017","journal-title":"Biomol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/ctm.ctm_69_16","article-title":"Stemness-Related Markers in Cancer","volume":"3","author":"Zhao","year":"2017","journal-title":"Cancer Transl. Med."},{"key":"ref_29","first-page":"1468","article-title":"Mutational spectrum and classification of novel mutations in patients with metastatic gastrointestinal stromal tumours","volume":"56","author":"Bombac","year":"2020","journal-title":"Int. J. Oncol."},{"key":"ref_30","first-page":"413","article-title":"Correlation of imatinib resistance with the mutational status of KIT and PDGFRA genes in gastrointestinal stromal tumors: A meta-analysis","volume":"22","author":"Lee","year":"2013","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/cncr.31234","article-title":"Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56\/07)","volume":"124","author":"Montemurro","year":"2018","journal-title":"Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pharmthera.2018.06.016","article-title":"Structural and clinical consequences of activation loop mutations in class III receptor tyrosine kinases","volume":"191","author":"Klug","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/cas.13533","article-title":"Stemness and anti-cancer drug resistance in ATP-binding cassette subfamily G member 2 highly expressed pancreatic cancer is induced in 3D culture conditions","volume":"109","author":"Sasaki","year":"2018","journal-title":"Cancer Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_35","first-page":"760","article-title":"SOX13 regulates cancer stem-like properties and tumorigenicity in hepatocellular carcinoma cells","volume":"11","author":"Jiao","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1038\/s41388-021-01729-1","article-title":"Transmembrane and coiled-coil domain family 3 (TMCC3) regulates breast cancer stem cell and AKT activation","volume":"40","author":"Wang","year":"2021","journal-title":"Oncogene"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.dmpk.2014.12.001","article-title":"A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development","volume":"30","author":"Oda","year":"2015","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41416-019-0722-0","article-title":"Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression","volume":"122","author":"Allain","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ccell.2020.03.006","article-title":"Response and Resistance to BCR-ABL1-Targeted Therapies","volume":"37","author":"Braun","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMoa1306494","article-title":"A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias","volume":"369","author":"Cortes","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1038\/s41375-019-0427-7","article-title":"Stem cell persistence in CML is mediated by extrinsically activated JAK1-STAT3 signaling","volume":"33","author":"Kuepper","year":"2019","journal-title":"Leukemia"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1038\/s41388-021-01732-6","article-title":"Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B","volume":"40","author":"Rubio","year":"2021","journal-title":"Oncogene"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12185-016-2028-9","article-title":"High IL-7 levels in the bone marrow microenvironment mediate imatinib resistance and predict disease progression in chronic myeloid leukemia","volume":"104","author":"Zhang","year":"2016","journal-title":"Int. J. Hematol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1038\/bcj.2017.29","article-title":"Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients","volume":"7","author":"Thiant","year":"2017","journal-title":"Blood Cancer J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nature18288","article-title":"Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells","volume":"534","author":"Abraham","year":"2016","journal-title":"Nature"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood-2005-09-3732","article-title":"A MAPK\/HNRPK pathway controls BCR\/ABL oncogenic potential by regulating MYC mRNA translation","volume":"107","author":"Notari","year":"2006","journal-title":"Blood"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.3324\/haematol.2018.193086","article-title":"BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia","volume":"103","author":"Srutova","year":"2018","journal-title":"Haematologica"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e1146","DOI":"10.1002\/ctm2.1146","article-title":"Loss of G0\/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism","volume":"12","author":"Gonzalez","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1126\/science.1252809","article-title":"Caspase-mediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure","volume":"344","author":"Segawa","year":"2014","journal-title":"Science"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"eaba9319","DOI":"10.1126\/sciadv.aba9319","article-title":"Live-cell imaging and analysis reveal cell phenotypic transition dynamics inherently missing in snapshot data","volume":"6","author":"Wang","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cell.2014.04.018","article-title":"RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3","volume":"157","author":"Dillon","year":"2014","journal-title":"Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e2758","DOI":"10.1038\/cddis.2017.156","article-title":"Robust high-throughput kinetic analysis of apoptosis with real-time high-content live-cell imaging","volume":"8","author":"Gelles","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Lin, C.L., Tsai, M.L., Lin, C.Y., Hsu, K.W., Hsieh, W.S., Chi, W.M., Huang, L.C., and Lee, C.H. (2019). HDAC1 and HDAC2 Double Knockout Triggers Cell Apoptosis in Advanced Thyroid Cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20020454"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/7\/616\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:22:35Z","timestamp":1760106155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/7\/616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":53,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["cells13070616"],"URL":"https:\/\/doi.org\/10.3390\/cells13070616","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,2]]}}}